<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Congenital aganglionic megacolon (Hirschsprung disease)
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Congenital aganglionic megacolon (Hirschsprung disease)
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Congenital aganglionic megacolon (Hirschsprung disease)
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Monica Esperanza Lopez, MD, MS
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jonathan I Singer, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            B UK Li, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Alison G Hoppin, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Aug 05, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hirschsprung disease (HD) is a motor disorder of the colon, which is caused by the failure of neural crest cells (precursors of enteric ganglion cells) to migrate completely during intestinal development during fetal life. The resulting aganglionic segment of the colon fails to relax, causing a functional obstruction.
        </p>
        <p>
         The pathogenesis, diagnosis, and clinical management of HD are discussed below. The emergency complications of HD, including acute obstruction in the neonate, Hirschsprung-associated enterocolitis (HAEC), and volvulus, are discussed in a separate topic review. (See
         <a class="medical medical_review" href="/z/d/html/5891.html" rel="external">
          "Emergency complications of Hirschsprung disease"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H11266174">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         HD occurs in approximately 1 in 5000 live births, with an overall male:female ratio of 3:1 to 4:1 [
         <a href="#rid1">
          1-3
         </a>
         ]. The sex ratio decreases with more extensive aganglionosis, approaching 1:1 for total colon aganglionosis. There is familial clustering for nonsyndromic HD, with an overall recurrence risk of approximately 3 percent in siblings for short-segment disease or up to 17 percent if the proband has long-segment disease [
         <a href="#rid4">
          4
         </a>
         ]. This sibling recurrence risk is higher if the proband is a female and is also higher if multiple family members are affected.
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          PATHOPHYSIOLOGY
         </span>
        </p>
        <p class="headingAnchor" id="H4211279207">
         <span class="h2">
          Embryology
         </span>
         <span class="headingEndMark">
          —
         </span>
         The most accepted theory of the cause of HD is that there is a defect in the craniocaudal migration of neuroblasts originating from the neural crest, a process that begins at four weeks of gestation and ends at week 7 with the arrival of neural crest-derived cells at the distal end of the colon [
         <a href="#rid5">
          5
         </a>
         ]. In HD, the cells fail to reach the distal colon, rendering that segment aganglionic and therefore with abnormal motor function, resulting in HD. Defects in the differentiation of neuroblasts into ganglion cells and ganglion cell destruction within the intestine may also contribute to the disorder [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2002305916">
         <span class="h2">
          Genetics
         </span>
         <span class="headingEndMark">
          —
         </span>
         Mutations in several genes have been identified in patients with HD [
         <a href="#rid7">
          7,8
         </a>
         ]. HD is a genetically complex disorder caused by variants in multiple rare genes with low penetrance and variable expression [
         <a href="#rid9">
          9
         </a>
         ]. Thus, individuals with multiple pathogenic variants have substantially increased risk compared with those with fewer pathogenic variants. For nonsyndromic forms, long-segment disease tends to be transmitted by autosomal dominant inheritance and short-segment disease often reflects autosomal recessive or multifactorial inheritance [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p>
         The predominant gene affected is the
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F164761&amp;token=tEpDslnpc0F0kICl%2Fz7sFQZkXc5y3Ni5EtCdXl4313XdrjBF4YggrN0XXW7Hbx%2BH&amp;TOPIC_ID=5903" target="_blank">
          <i>
           RET
          </i>
         </a>
         proto-oncogene.
         <em>
          RET
         </em>
         is essential for normal enteric nervous system development, and pathogenic mutations cause a loss of intestinal motor function. More than 20 different mutations in
         <em>
          RET
         </em>
         have been described [
         <a href="#rid11">
          11,12
         </a>
         ]. Coding sequence mutations in
         <em>
          RET
         </em>
         are identified in approximately one-half of all familial cases and approximately one-third of sporadic cases. In one study,
         <em>
          RET
         </em>
         variants were found in 82 percent of patients with total colonic aganglionosis (TCA), compared with 33 percent of those with short-segment disease [
         <a href="#rid13">
          13
         </a>
         ] (see
         <a class="local">
          'Clinical features'
         </a>
         below). In addition, certain
         <em>
          RET
         </em>
         polymorphisms are associated with particular phenotypes of HD (short- or long-segment disease) [
         <a href="#rid11">
          11
         </a>
         ]. Most Hirschsprung cases are linked to
         <em>
          RET
         </em>
         , even without an identified coding sequence mutation, suggesting that noncoding variants of this gene play a major role in the disease by causing loss of function of the RET receptor tyrosine kinase that appears to transduce growth and differentiation signals in developing tissues, including those derived from the neural crest. Mouse models have demonstrated that RET protein is necessary for migration, survival, proliferation, and differentiation of the neural crest-derived cells that give rise to the enteric nervous system, and the degree of aganglionosis is proportionate to RET dose [
         <a href="#rid14">
          14
         </a>
         ]. Pathogenic variants in
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F600837&amp;token=tEpDslnpc0F0kICl%2Fz7sFUfdC7kgbt7z3sRDeh8bdyr1%2BJ0E2TZbopm3ZYRB3k6Z&amp;TOPIC_ID=5903" target="_blank">
          <i>
           GDNF
          </i>
         </a>
         or
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F602018&amp;token=tEpDslnpc0F0kICl%2Fz7sFUfdC7kgbt7z3sRDeh8bdyryTCqebaDTbfTEWmutvVd6&amp;TOPIC_ID=5903" target="_blank">
          <i>
           NRTN
          </i>
         </a>
         , which encode ligands for receptors that activate RET, have also been linked to HD in some individuals [
         <a href="#rid7">
          7,15
         </a>
         ].
        </p>
        <p>
         The second major gene involved in HD is
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F131244&amp;token=tEpDslnpc0F0kICl%2Fz7sFc6jRLzqNN8gxZwGEOirhGnjwfnlfJLWI%2FXFZJD2ITPd&amp;TOPIC_ID=5903" target="_blank">
          <i>
           EDNRB
          </i>
         </a>
         , which encodes a G-protein-coupled receptor [
         <a href="#rid16">
          16
         </a>
         ], with a ligand encoded by
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F131242&amp;token=tEpDslnpc0F0kICl%2Fz7sFc6jRLzqNN8gxZwGEOirhGlHomh%2FmoDydU7ANr3GFLPS&amp;TOPIC_ID=5903" target="_blank">
          <i>
           EDN3
          </i>
         </a>
         . The proteins encoded by
         <em>
          EDNRB
         </em>
         and
         <em>
          EDN3
         </em>
         are involved in the development of neural crest cells.
        </p>
        <p>
         The genetic mechanisms underlying the strong association between Down syndrome (trisomy 21) and HD have not been established. It is likely that multiple mechanisms are involved in this association, including specific
         <em>
          RET
         </em>
         variants and variants in
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F602523&amp;token=tEpDslnpc0F0kICl%2Fz7sFUfdC7kgbt7z3sRDeh8bdyoIbpkHxSvrqwhaBDhE3eTV&amp;TOPIC_ID=5903" target="_blank">
          <i>
           DSCAM
          </i>
         </a>
         (Down syndrome cell adhesion model) gene region on chromosome 21 [
         <a href="#rid17">
          17,18
         </a>
         ].
        </p>
        <p>
         Pathogenic variants in other genes have been described in a minority of patients [
         <a href="#rid7">
          7
         </a>
         ]. These genes include
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F131242&amp;token=tEpDslnpc0F0kICl%2Fz7sFc6jRLzqNN8gxZwGEOirhGlHomh%2FmoDydU7ANr3GFLPS&amp;TOPIC_ID=5903" target="_blank">
          <i>
           EDN3
          </i>
         </a>
         ,
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F600423&amp;token=tEpDslnpc0F0kICl%2Fz7sFUfdC7kgbt7z3sRDeh8bdypYoT28mCvhcZBS2fTur5cw&amp;TOPIC_ID=5903" target="_blank">
          <i>
           ECE1
          </i>
         </a>
         ,
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F602229&amp;token=tEpDslnpc0F0kICl%2Fz7sFUfdC7kgbt7z3sRDeh8bdypEv4%2FIJ6Q7wgVFOs%2B8jfhB&amp;TOPIC_ID=5903" target="_blank">
          <i>
           SOX10
          </i>
         </a>
         , and
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F603851&amp;token=tEpDslnpc0F0kICl%2Fz7sFUfdC7kgbt7z3sRDeh8bdyoOF4WjZv7AB2tV%2FFI06aW1&amp;TOPIC_ID=5903" target="_blank">
          <i>
           PHOX2B
          </i>
         </a>
         [
         <a href="#rid19">
          19,20
         </a>
         ]. A genome-wide association study also identified an association with
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F142445&amp;token=tEpDslnpc0F0kICl%2Fz7sFYR8Q1aXDxBReNYTLBTBwCSh1y48BZZHO1ot2Ozl43ND&amp;TOPIC_ID=5903" target="_blank">
          <i>
           NRG1
          </i>
         </a>
         , a regulator of enteric ganglia precursors [
         <a href="#rid21">
          21
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Associated syndromes
         </span>
         <span class="headingEndMark">
          —
         </span>
         HD is associated with chromosomal anomalies, so-called syndromic HD, especially Down syndrome  (
         <a class="graphic graphic_table graphicRef101015" href="/z/d/graphic/101015.html" rel="external">
          table 1
         </a>
         ). Down syndrome is present in 2 to 16 percent of individuals with HD [
         <a href="#rid22">
          22,23
         </a>
         ]. Conversely, HD occurs in less than 1 percent of individuals with Down syndrome, although the overall risk of HD in Down syndrome is much higher than in the general population [
         <a href="#rid10">
          10,24
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2917.html" rel="external">
          "Down syndrome: Clinical features and diagnosis", section on 'Gastrointestinal abnormalities'
         </a>
         .)
        </p>
        <p>
         HD is also associated with several different monogenic syndromes  (
         <a class="graphic graphic_table graphicRef73215" href="/z/d/graphic/73215.html" rel="external">
          table 2
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Bardet-Biedl syndrome. (See
         <a class="medical medical_review" href="/z/d/html/5378.html" rel="external">
          "Obesity: Genetic contribution and pathophysiology", section on 'Bardet-Biedl syndrome'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cartilage-hair hypoplasia (
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F250250&amp;token=tEpDslnpc0F0kICl%2Fz7sFb7RHexADzCKuy2%2Bv61th%2FnTC3sW7C3Cy%2FSD%2F%2BdgYMVq&amp;TOPIC_ID=5903" target="_blank">
          MIM #250250
         </a>
         ) – This is a rare syndrome characterized by short stature, short limbs with increased carrying angle at the elbow, increased lumbar lordosis, ligamentous laxity, scoliosis, and immunodeficiency. Affected infants often present with enterocolitis. (See
         <a class="medical medical_review" href="/z/d/html/3916.html" rel="external">
          "Cartilage-hair hypoplasia", section on 'Gastrointestinal abnormalities'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Congenital central hypoventilation syndrome (CCHS). The association of CCHS and HD is known as Haddad syndrome. (See
         <a class="medical medical_review" href="/z/d/html/97858.html" rel="external">
          "Congenital central hypoventilation syndrome and other causes of sleep-related hypoventilation in children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Familial dysautonomia (also known as hereditary sensory and autonomic neuropathy type 3, or Riley-Day syndrome). (See
         <a class="medical medical_review" href="/z/d/html/6227.html" rel="external">
          "Hereditary sensory and autonomic neuropathies", section on 'HSAN3 (Familial dysautonomia)'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Multiple endocrine neoplasia type 2 (MEN2), which is characterized by medullary thyroid cancer and pheochromocytoma, with or without primary hyperparathyroidism. Type 2A is associated with HD. (See
         <a class="medical medical_review" href="/z/d/html/7870.html" rel="external">
          "Clinical manifestations and diagnosis of multiple endocrine neoplasia type 2"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Mowat-Wilson syndrome (
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F235730&amp;token=tEpDslnpc0F0kICl%2Fz7sFQJ0cbFqQ2rqnHzdjc4VeV2W8b4hbqfQwwh64%2FD%2F5pa%2B&amp;TOPIC_ID=5903" target="_blank">
          MIM #235730
         </a>
         ) – This is caused by haploinsufficiency of the
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F605802&amp;token=tEpDslnpc0F0kICl%2Fz7sFUfdC7kgbt7z3sRDeh8bdyrGZyd58RTU%2BISdTIbgN4tK&amp;TOPIC_ID=5903" target="_blank">
          <i>
           ZEB2
          </i>
         </a>
         gene [
         <a href="#rid25">
          25-27
         </a>
         ]. Approximately 50 percent of individuals with Mowat-Wilson syndrome have HD; other features are distinctive facial characteristics, moderate to severe intellectual disability, genitourinary anomalies, and heart defects.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Smith-Lemli-Opitz syndrome (
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F270400&amp;token=tEpDslnpc0F0kICl%2Fz7sFWdn73fzwsrnK0ZHvwqS9sZ2OuejNXMRnhSFk9cf1utA&amp;TOPIC_ID=5903" target="_blank">
          MIM #270400
         </a>
         ) [
         <a href="#rid28">
          28-31
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5813.html" rel="external">
          "Causes of primary adrenal insufficiency in children", section on 'Defects in cholesterol biochemistry'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Waardenburg syndrome – This is an autosomal dominant inherited pigmentary disorder; nearly 100 percent of Waardenburg syndrome type 4 have HD. (See
         <a class="medical medical_review" href="/z/d/html/3004.html" rel="external">
          "The genodermatoses: An overview", section on 'Waardenburg syndrome'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         For Down syndrome, Bardet-Biedl syndrome, and CCHS,
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F164761&amp;token=tEpDslnpc0F0kICl%2Fz7sFQZkXc5y3Ni5EtCdXl4313XdrjBF4YggrN0XXW7Hbx%2BH&amp;TOPIC_ID=5903" target="_blank">
          <i>
           RET
          </i>
         </a>
         acts as a modifier gene for the Hirschsprung phenotype. Assessment by a clinical geneticist is valuable for all patients with syndromic features or anomalies and also for those with no apparent associated anomalies. (See
         <a class="medical medical_review" href="/z/d/html/2917.html" rel="external">
          "Down syndrome: Clinical features and diagnosis", section on 'Gastrointestinal abnormalities'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5113.html" rel="external">
          "Disorders of ventilatory control", section on 'Congenital central hypoventilation syndrome'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3004.html" rel="external">
          "The genodermatoses: An overview", section on 'Waardenburg syndrome'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h1">
          CLINICAL FEATURES
         </span>
        </p>
        <p class="headingAnchor" id="H32164234">
         <span class="h2">
          Types of aganglionosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         In approximately 80 percent of patients, HD affects the rectosigmoid colon (known as short-segment disease) [
         <a href="#rid4">
          4,10
         </a>
         ]. In 15 to 20 percent of patients, the aganglionosis extends proximal to the sigmoid colon (known as long-segment disease). In approximately 5 percent, the entire colon is affected (known as total colonic aganglionosis [TCA]), and, in rare cases, the small bowel may also be involved [
         <a href="#rid32">
          32
         </a>
         ]. Outcomes are generally worse for patients with long-segment as compared with short-segment disease.
        </p>
        <p class="headingAnchor" id="H383682667">
         <span class="h2">
          Clinical presentation
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Neonatal
         </strong>
         – The majority of patients with HD are diagnosed in the neonatal period. Affected infants present with symptoms of distal intestinal obstruction: bilious emesis, abdominal distension, and failure to pass meconium or stool [
         <a href="#rid33">
          33
         </a>
         ]. The diagnosis is suggested by a delay in passage of the first meconium. By 48 hours of life, 100 percent of normal full-term neonates will pass meconium [
         <a href="#rid34">
          34
         </a>
         ]. In contrast, 45 to 90 percent of infants with HD will fail to pass meconium within the first 48 hours of life [
         <a href="#rid35">
          35-37
         </a>
         ]. Therefore, passage of stool within the first one to two days of life does not exclude the diagnosis. Another suggestive sign of HD in a neonate is an explosive expulsion of gas and liquid stool after the digital rectal examination (squirt sign or blast sign), which may relieve the obstruction temporarily [
         <a href="#rid38">
          38
         </a>
         ]. In some infants with HD, the typical clinical features (poor feeding, abdominal distension, and constipation) first become apparent if feeds are switched from breast milk to formula.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Affected infants also may present initially with enterocolitis, a potentially life-threatening illness in which patients have a sepsis-like picture with fever, vomiting, diarrhea, and abdominal distension, which can progress to toxic megacolon. Patients with enterocolitis require stopping oral intake, intravenous fluid resuscitation, intravenous antibiotic therapy including coverage for anaerobic bacteria, rectal irrigations, and, in rare cases, an emergency colostomy. (See
         <a class="local">
          'Suspected enterocolitis'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/5891.html" rel="external">
          "Emergency complications of Hirschsprung disease"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         A rare complication of HD is volvulus, which predominantly affects the sigmoid or, less commonly, the transverse colon and cecum. Even less commonly, HD can present with appendiceal perforation [
         <a href="#rid39">
          39
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Older infants or children
         </strong>
         – Patients with less severe disease (usually because they have short-segment disease) may not be diagnosed until later in infancy or childhood; in approximately 10 percent of individuals, HD is diagnosed after three years of age [
         <a href="#rid40">
          40,41
         </a>
         ]. Such patients typically have a history of chronic constipation and failure to thrive. Although uncommon, HD can be newly diagnosed in adulthood. Patients present with symptoms of abdominal distension and a long history of refractory constipation without fecal incontinence [
         <a href="#rid42">
          42,43
         </a>
         ]. Some of these patients may have "ultrashort-segment HD" (USSHD), which is described below. (See
         <a class="local">
          'Ultrashort-segment Hirschsprung disease'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/99538.html" rel="external">
          "Functional constipation in infants, children, and adolescents: Clinical features and diagnosis", section on 'Differential diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1756321438">
         <span class="h2">
          Associated congenital anomalies
         </span>
         <span class="headingEndMark">
          —
         </span>
         Approximately 20 to 25 percent of patients with HD have associated congenital anomalies  (
         <a class="graphic graphic_figure graphicRef100632" href="/z/d/graphic/100632.html" rel="external">
          figure 1
         </a>
         ), often but not always in association with one of the syndromes described above. (See
         <a class="local">
          'Associated syndromes'
         </a>
         above.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Genitourinary anomalies
         </strong>
         – Congenital anomalies of the kidney and urinary tract (CAKUT), including hydronephrosis and renal hypoplasia, are particularly common [
         <a href="#rid22">
          22,44,45
         </a>
         ]. These associations are not explained by a simple relationship with
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F164761&amp;token=tEpDslnpc0F0kICl%2Fz7sFQZkXc5y3Ni5EtCdXl4313XdrjBF4YggrN0XXW7Hbx%2BH&amp;TOPIC_ID=5903" target="_blank">
          <i>
           RET
          </i>
         </a>
         or
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F600837&amp;token=tEpDslnpc0F0kICl%2Fz7sFUfdC7kgbt7z3sRDeh8bdyr1%2BJ0E2TZbopm3ZYRB3k6Z&amp;TOPIC_ID=5903" target="_blank">
          <i>
           GDNF
          </i>
         </a>
         , but these genes could be involved as disease modifiers. In a report of 106 HD patients who underwent routine ultrasonographic screening, CAKUT were found in approximately 20 percent of individuals with nonsyndromic HD and 40 percent of those with syndromic HD [
         <a href="#rid22">
          22
         </a>
         ]. Because of this high frequency, some experts recommend routine ultrasonographic screening for urinary system malformations in infants with HD, especially in those with syndromic HD [
         <a href="#rid46">
          46
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6110.html" rel="external">
          "Overview of congenital anomalies of the kidney and urinary tract (CAKUT)"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6106.html" rel="external">
          "Evaluation of congenital anomalies of the kidney and urinary tract (CAKUT)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Visual and hearing impairment
         </strong>
         – In one case series, ophthalmologic abnormalities were found in approximately 40 percent of individuals with HD. Most were refractive errors (hyperopia, astigmatism, or myopia), but visual impairment was present in 9.4 percent [
         <a href="#rid22">
          22
         </a>
         ]. Hearing impairment was found in approximately 5 percent of individuals with HD, approximately three times the rate in the general population. These findings support routine screening for hearing impairment for children with HD, using protocols for infants at increased risk. (See
         <a class="medical medical_review" href="/z/d/html/4985.html" rel="external">
          "Screening the newborn for hearing loss"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6297.html" rel="external">
          "Hearing loss in children: Screening and evaluation"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Congenital heart disease
         </strong>
         – Congenital heart disease is found in approximately 50 percent of individuals with syndromic HD (usually Down syndrome) [
         <a href="#rid22">
          22
         </a>
         ] but is unusual in patients without an associated syndrome [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Anorectal malformations
         </strong>
         – HD may also occur in association with anorectal malformations; the possibility of HD should be considered in patients with anorectal malformations who develop constipation that does not respond to standard treatment and in those with other symptoms suggestive of HD [
         <a href="#rid47">
          47
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h1">
          EVALUATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         HD should be suspected in patients with the clinical symptoms described above. A high index of suspicion is appropriate for neonates and infants with a predisposing condition, such as Down syndrome, or for those with a family history of HD  (
         <a class="graphic graphic_algorithm graphicRef51156" href="/z/d/graphic/51156.html" rel="external">
          algorithm 1
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H166160002">
         <span class="h2">
          Indications for testing
         </span>
        </p>
        <p class="headingAnchor" id="H166160112">
         <span class="h3">
          Suspected Hirschsprung disease in neonates
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          High suspicion
         </strong>
         – A high suspicion for HD is suggested by the following characteristics in infants &lt;6 months of age:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Symptoms of intestinal obstruction, including bilious emesis, abdominal distension, and failure to pass stool
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Failure to pass meconium within 48 hours of birth
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Constipation and any of the following:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Down syndrome (trisomy 21) or other condition known to be associated with HD
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Family history of HD
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Physical examination suggestive of HD (abdominal distension, tight anal sphincter, narrowed rectum, or squirt sign on digital examination) (see
         <a class="local">
          'Clinical features'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Such infants should have an urgent full evaluation for HD, usually consisting of a contrast enema and rectal suction biopsy  (
         <a class="graphic graphic_algorithm graphicRef51156" href="/z/d/graphic/51156.html" rel="external">
          algorithm 1
         </a>
         ). (See
         <a class="local">
          'Diagnostic testing'
         </a>
         below and
         <a class="local">
          'Rectal biopsy'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Moderate suspicion
         </strong>
         – A moderate level of suspicion for HD is warranted for neonates with a well-documented, moderate delay in passing meconium (&gt;48 hours but &lt;72 hours) but no other symptoms (no abdominal distension, vomiting, or feeding problems).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Practice varies regarding the management of these infants. They should undergo a careful physical examination and exclusion of other causes of delayed passage of meconium, including anorectal malformations  (
         <a class="graphic graphic_table graphicRef82181" href="/z/d/graphic/82181.html" rel="external">
          table 3
         </a>
         ) (see
         <a class="medical medical_review" href="/z/d/html/5906.html" rel="external">
          "Constipation in infants and children: Evaluation", section on 'Physical examination'
         </a>
         ). They should also be closely observed and evaluated promptly for HD if they develop symptoms of constipation or abdominal distension.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Anorectal manometry is a useful screening test in patients with mild to moderate symptoms (see
         <a class="local">
          'Anorectal manometry'
         </a>
         below). Alternatively, it is reasonable to perform a contrast enema and suction rectal biopsy in such infants, particularly if close observation cannot be assured. An urgent evaluation is essential if the infant develops symptoms of obstruction or enterocolitis.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H269127604">
         <span class="h3">
          Suspected enterocolitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Urgent evaluation for Hirschsprung-associated enterocolitis (HAEC) is indicated for any neonate or infant with known or suspected HD who presents with fever, vomiting, abdominal distension, and explosive diarrhea. This includes infants who have undergone surgical repair for HD or those with risk factors such as Down syndrome or a family history of HD. Other concerning symptoms include lethargy or obstipation  (
         <a class="graphic graphic_table graphicRef114001" href="/z/d/graphic/114001.html" rel="external">
          table 4
         </a>
         ) [
         <a href="#rid48">
          48
         </a>
         ]. HAEC seldom occurs in neonates except when the diagnosis of HD is missed or delayed. The diagnosis of HD or HAEC can be missed in an infant who has an atypical subacute presentation of chronic diarrhea and poor weight gain [
         <a href="#rid49">
          49
         </a>
         ].
        </p>
        <p>
         All such patients should have a rectal examination, performed either with a finger (digital) or with a small-diameter anal dilator; an explosive release of gas and liquid stool during this examination supports a diagnosis of HAEC. The evaluation should also include an abdominal radiograph. The possibility of HAEC is supported by signs of ileus, including air-fluid levels and dilated bowel. A contrast enema should
         <strong>
          not
         </strong>
         be performed if HAEC is suspected, because of the risk of bacterial translocation with subsequent septicemia and/or intestinal perforation.
        </p>
        <p>
         Evaluation, diagnosis, and management of HAEC are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5891.html" rel="external">
          "Emergency complications of Hirschsprung disease", section on 'Enterocolitis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2357687094">
         <span class="h3">
          Chronic refractory constipation
         </span>
         <span class="headingEndMark">
          —
         </span>
         For older infants and toddlers with chronic refractory constipation (ages three months to three years), the level of suspicion for HD is guided by the history and physical examination:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For those with failure to thrive and other signs suggestive of HD on physical examination (abdominal distension, narrowed rectum without stool present, tight anal sphincter, or squirt sign on examination), a moderate level of suspicion for HD is warranted. These individuals should be evaluated for HD, but the timing and sequence of diagnostic testing is elective. In this group, anorectal manometry is an excellent screening test if it is available. A normal anorectal inhibitory reflex excludes HD. (See
         <a class="local">
          'Anorectal manometry'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For those with
         <strong>
          no
         </strong>
         symptoms or signs suggestive of HD other than constipation, a lower degree of suspicion for HD is warranted. For such patients, it is reasonable to evaluate with a plain radiograph and base further testing on the results. (See
         <a class="local">
          'Abdominal radiograph'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H166160008">
         <span class="h2">
          Diagnostic testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         Rectal biopsy is the gold standard for diagnosis.
        </p>
        <p>
         Before proceeding to rectal biopsy, we typically perform noninvasive testing with contrast enema and/or anorectal manometry. Each of these procedures has advantages and disadvantages related to availability, technical expertise, radiation exposure, and invasiveness [
         <a href="#rid50">
          50
         </a>
         ]. The diagnostic steps depend on the level of suspicion for HD, age of the child, whether there is concern about HAEC (which requires emergency management), and on the available resources and institutional/clinician preference  (
         <a class="graphic graphic_algorithm graphicRef51156" href="/z/d/graphic/51156.html" rel="external">
          algorithm 1
         </a>
         ).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In our practice, we generally perform a contrast enema rather than suction biopsy as the initial diagnostic procedure. If a clear transition zone is seen on
         <a class="drug drug_general" data-topicid="9180" href="/z/d/drug information/9180.html" rel="external">
          barium
         </a>
         enema, the study is virtually pathognomonic of HD and helps the surgeon plan the operative approach. If a transition zone is not seen, HD cannot be entirely excluded. We always confirm the diagnosis by rectal biopsy even when the barium enema shows typical features of HD.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Some clinicians start the evaluation with anorectal manometry, if the findings are abnormal, followed by rectal suction biopsy during the same procedure. Anorectal manometry is particularly useful for the evaluation of older children with possible HD because a normal result excludes HD and avoids more invasive procedures.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2513409901">
         <span class="h3">
          Contrast enema
         </span>
         <span class="headingEndMark">
          —
         </span>
         In infants with suspected HD, a contrast enema can support the diagnosis of HD; it is performed without stool cleanout ("unprepped"). However, this test is not sufficient to exclude the diagnosis of HD, especially in newborns or other individuals with a high clinical suspicion for the disease [
         <a href="#rid51">
          51,52
         </a>
         ]. The rectum and colon may look relatively normal in cases of long-segment or total colonic HD. A contrast enema is also useful for presurgical planning because it may help the surgeon to localize the transition zone and determine the length of the aganglionic segment [
         <a href="#rid50">
          50
         </a>
         ], although the location of the transition zone on imaging does not always match its true pathologic location [
         <a href="#rid53">
          53
         </a>
         ].
        </p>
        <p>
         The presence of a "transition zone," which represents the change from the normal caliber/narrowed rectum (aganglionic segment) to the dilated colon proximal to the aganglionic region, is virtually pathognomonic of HD  (
         <a class="graphic graphic_diagnosticimage graphicRef59877" href="/z/d/graphic/59877.html" rel="external">
          image 1
         </a>
         ). Despite this high degree of certainty, we always confirm the diagnosis by rectal biopsy before surgery. The transition zone usually is in the rectosigmoid area and is seen best in the early lateral and oblique views. In patients with total colonic involvement, the entire colon may appear relatively normal, but dilated loops of distal small bowel may be visible [
         <a href="#rid54">
          54
         </a>
         ]. If a transition zone is not clearly detected, a follow-up postevacuation film 24 hours later may reveal residual retained contrast in the colon, which is suggestive of the diagnosis [
         <a href="#rid55">
          55
         </a>
         ]. The rectosigmoid index (RSI), the ratio between the diameter of the rectum and the sigmoid colon, is typically &gt;1 in normal children. Reversal of this ratio, although less often noted than a transition zone, is a useful sign of HD in infants and older children [
         <a href="#rid56">
          56,57
         </a>
         ].
        </p>
        <p>
         The use of contrast enema for diagnosis of HD is limited by false-negative results, which render this test less sensitive than rectal suction biopsy and anorectal manometry for the diagnosis of HD  (
         <a class="graphic graphic_table graphicRef65223" href="/z/d/graphic/65223.html" rel="external">
          table 5
         </a>
         ) [
         <a href="#rid50">
          50,58
         </a>
         ]. As an example, a digital rectal examination within a few days prior to the contrast enema may dilate the rectum and cause a false-negative result. Similarly, classic radiographic findings such as inversion of the RSI may not be evident in studies performed in the early newborn period or in premature infants [
         <a href="#rid59">
          59
         </a>
         ]. Therefore, a normal contrast enema is not sufficient to exclude the diagnosis of HD in a neonate with a high clinical suspicion of disease. In a single-center retrospective study of newborns who were clinically suspected to have HD, 32 percent of those who had inconclusive findings on contrast enema were ultimately diagnosed with HD, compared with 2.5 percent of those with negative findings on contrast enema [
         <a href="#rid51">
          51
         </a>
         ]. However, in patients with a low clinical suspicion of HD, a contrast enema provides good evidence to exclude the diagnosis. This was shown in a study that compared 50 children who presented with constipation and were diagnosed with HD with a concurrent cohort of 50 patients with idiopathic constipation [
         <a href="#rid60">
          60
         </a>
         ]. Significantly more patients with HD experienced delayed passage of meconium, abdominal distension, and vomiting and had a transition zone identified on a contrast enema. The presence of at least one of these findings was identified in every patient diagnosed with HD compared with 64 percent of patients with idiopathic constipation. Thus, the authors suggest that rectal biopsy may be avoided in children with constipation who lack all three of these clinical and radiologic features.
        </p>
        <p class="headingAnchor" id="H3030281336">
         <span class="h3">
          Anorectal manometry
         </span>
         <span class="headingEndMark">
          —
         </span>
         Anorectal manometry sometimes is a very useful aid in the diagnosis and is especially helpful in patients with ultrashort-segment HD (USSHD), eg, in older children presenting with chronic refractory constipation. It is helpful as a screening test because a clearly normal study demonstrating relaxation of the internal anal sphincter with distension of the rectum excludes the diagnosis of HD. Lack of relaxation of the internal anal sphincter with balloon rectal distension is suggestive of HD, but false positives can occur. Anorectal manometry has a positive predictive value that is reported to be 75 to 95 percent but is less accurate in infants younger than one month of age and those with longstanding chronic constipation [
         <a href="#rid58">
          58,61,62
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5906.html" rel="external">
          "Constipation in infants and children: Evaluation", section on 'Anorectal manometry'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3172127411">
         <span class="h3">
          Rectal biopsy
         </span>
         <span class="headingEndMark">
          —
         </span>
         A suction rectal biopsy can be done at the bedside or in an ambulatory setting without the need for general anesthesia. A biopsy should be taken 2 cm above the level of the dentate line to avoid the physiologic 1- to 2-cm hypoganglionic or aganglionic zone that is normally present. A second biopsy should be taken proximal to the first one. Although adequate tissue is obtained for analysis in the majority of infants and toddlers, in children above age three years, the rate of adequate tissue declines progressively from 88 percent to 70 and 45 percent (in adolescents) [
         <a href="#rid63">
          63-65
         </a>
         ]. Repeat suction biopsies, grasp-forceps biopsies, or full-thickness biopsies under general anesthesia can be performed if the initial biopsy is nondiagnostic (ie, if insufficient tissue is obtained).
        </p>
        <p>
         The diagnosis of HD is established if ganglion cells are absent in the rectal biopsy, provided that the tissue sample is adequate  (
         <a class="graphic graphic_picture graphicRef53381" href="/z/d/graphic/53381.html" rel="external">
          picture 1
         </a>
         ). Supportive findings include the presence of hypertrophic nerve fibers, increased acetylcholinesterase activity or staining in the muscularis mucosae, and decreased or absent calretinin-immunoreactive fibers in the lamina propria [
         <a href="#rid66">
          66-69
         </a>
         ]. Excessively thickened nerve fibers may not appear until after eight weeks of age [
         <a href="#rid70">
          70
         </a>
         ]. (See
         <a class="local">
          'Diagnosis'
         </a>
         below.)
        </p>
        <p>
         A normal rectal biopsy virtually excludes HD, provided that the biopsy samples are obtained from the correct site and contain at least a small amount of muscularis mucosae. Thus, a rectal suction biopsy is more sensitive and specific than contrast enema and anorectal manometry for the diagnosis of HD for children up to three years of age  (
         <a class="graphic graphic_table graphicRef65223" href="/z/d/graphic/65223.html" rel="external">
          table 5
         </a>
         ) [
         <a href="#rid50">
          50,58
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H166160486">
         <span class="h3">
          Abdominal radiograph
         </span>
         <span class="headingEndMark">
          —
         </span>
         A plain abdominal radiograph is not helpful in excluding the diagnosis of HD, except perhaps for patients in whom there is a low suspicion of disease (eg, children with moderate refractory constipation but no other clinical features of HD and a normal anorectal examination). If a plain radiograph is performed, the possibility of HD is suggested by signs of distal intestinal obstruction, ie, decreased or absent air in the rectum and dilated bowel loops proximal to the aganglionic region. Occasionally, careful review of the plain radiographs may reveal the transition zone even when it is not visible on the contrast enema [
         <a href="#rid71">
          71
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H166160218">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         HD is suspected based on clinical features described above, usually supported by contrast enema or anorectal manometry. (See
         <a class="local">
          'Contrast enema'
         </a>
         above and
         <a class="local">
          'Anorectal manometry'
         </a>
         above.)
        </p>
        <p>
         The diagnosis is established by rectal biopsy (a rectal suction biopsy and/or a full-thickness biopsy).
         <strong>
          Absence of ganglia
         </strong>
         on the suction biopsy confirms the diagnosis of HD, provided that the sample is adequate, meaning that the biopsies were obtained from the correct site and contain at least a small amount of muscularis mucosae. If ganglia are seen in an appropriately performed suction biopsy, HD is virtually excluded. (See
         <a class="local">
          'Rectal biopsy'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H3590715670">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other disorders that may present with intestinal obstruction in a newborn infant include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Gastrointestinal malformations, including intestinal stenosis or atresia, duplication cysts, or malrotation. (See
         <a class="medical medical_review" href="/z/d/html/5863.html" rel="external">
          "Intestinal atresia"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6477.html" rel="external">
          "Intestinal malrotation in children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Meconium ileus due to cystic fibrosis. (See
         <a class="medical medical_review" href="/z/d/html/5858.html" rel="external">
          "Cystic fibrosis: Overview of gastrointestinal disease", section on 'Meconium ileus'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Multiple endocrine neoplasia type 2 (MEN2). Type 2A is associated with HD, whereas type 2B may be associated with ganglioneuromatosis, skeletal deformations, and Marfanoid habitus. (See
         <a class="medical medical_review" href="/z/d/html/7870.html" rel="external">
          "Clinical manifestations and diagnosis of multiple endocrine neoplasia type 2"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Disorders causing chronic intestinal pseudo-obstruction, including intestinal neuronal dysplasia. (See
         <a class="medical medical_review" href="/z/d/html/2639.html" rel="external">
          "Chronic intestinal pseudo-obstruction: Etiology, clinical manifestations, and diagnosis", section on 'Genetic'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/99538.html" rel="external">
          "Functional constipation in infants, children, and adolescents: Clinical features and diagnosis", section on 'Other causes'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Meconium plug syndrome, a condition that occurs in up to 1:500 newborns and is due to colonic dysmotility or abnormal consistency of meconium, leading to obstipation in the newborn. A contrast enema is both diagnostic and therapeutic. However, approximately 15 percent of infants with meconium plug syndrome also have HD, so a full diagnostic evaluation for HD, including rectal suction biopsy, is warranted [
         <a href="#rid72">
          72
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Small left colon syndrome, which typically occurs in infants of diabetic mothers and appears to be due to transient left colon dysmotility, leading to delayed passage of stool. A contrast enema makes the diagnosis, showing a contracted left colon, and the problem usually resolves on its own after a few days. These neonates should undergo rectal biopsy to ensure that they do not have HD.
        </p>
        <p>
        </p>
        <p>
         These disorders can be distinguished from HD by their clinical features and the presence of ganglia on a rectal suction biopsy.
        </p>
        <p>
         In older infants and children, the main consideration in the differential diagnosis is functional constipation. Other possibilities include anorectal anomalies, internal anal sphincter achalasia, hypothyroidism, and chronic intestinal pseudo-obstruction (see
         <a class="medical medical_review" href="/z/d/html/99538.html" rel="external">
          "Functional constipation in infants, children, and adolescents: Clinical features and diagnosis"
         </a>
         ). Classical HD also should be distinguished from ultrashort-segment HD (USSHD), as discussed below. (See
         <a class="local">
          'Ultrashort-segment Hirschsprung disease'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h1">
          MANAGEMENT
         </span>
        </p>
        <p class="headingAnchor" id="H1748918091">
         <span class="h2">
          Surgical correction
         </span>
         <span class="headingEndMark">
          —
         </span>
         The mainstay of treatment is surgery. The goals are to resect the affected segment of the rectum and colon, bring the normal ganglionic bowel down to an anastomosis to the distal rectum close to the anus, and preserve internal anal sphincter function. Many surgical techniques have been developed. The choice among them usually is based on surgeon preference since the overall complication rates and long-term results are similar [
         <a href="#rid38">
          38,73
         </a>
         ].
        </p>
        <p>
         The traditional operation was an abdominoperineal pull-through in two or three stages, in which patients initially underwent a diverting colostomy (to allow the dilated bowel to decompress) with definitive repair performed later. However, most centers now perform the procedure in one stage, and this approach may decrease complication rates [
         <a href="#rid74">
          74-76
         </a>
         ]. Laparoscopic-assisted and transanal repairs are commonplace and are now preferred over the open procedures in most centers. The outcome seems to be equivalent to the traditional abdominoperineal pull-through, with the added benefits of earlier resumption of full feeds, less pain, shorter hospitalization, and less conspicuous scars [
         <a href="#rid77">
          77-80
         </a>
         ].
        </p>
        <p>
         In a systematic review and meta-analysis comparing totally transanal, endorectal, and laparoscopic-assisted pull-through, operative time was found to be shorter for the transanal procedure compared with the laparoscopically assisted one [
         <a href="#rid81">
          81
         </a>
         ]. In addition, the incidence of serious complications such as enterocolitis, incontinence, and chronic constipation did not differ between the two procedures. However, the frequency of postoperative internal anal sphincter defects identified by endosonography was higher in patients undergoing a transanal approach (69 versus 19 percent) [
         <a href="#rid82">
          82
         </a>
         ]. These findings should be confirmed with data from other centers and with longer lengths of follow-up to fully understand the implications of this operative approach.
        </p>
        <p>
         Patients with ultrashort-segment HD (USSHD) may not require a pull-through operation. (See
         <a class="local">
          'Ultrashort-segment Hirschsprung disease'
         </a>
         below.)
        </p>
        <p>
         Treatment of the emergency complications of HD, including acute bowel obstruction, enterocolitis, and volvulus, is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5891.html" rel="external">
          "Emergency complications of Hirschsprung disease"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H386470607">
         <span class="h2">
          Further evaluation for associated anomalies
         </span>
         <span class="headingEndMark">
          —
         </span>
         The clinician should be alert for signs or symptoms of congenital anomalies in patients with suspected HD. Genitourinary anomalies, hearing impairment, and visual impairment are common in all patients with HD and particularly those with syndromic HD  (
         <a class="graphic graphic_figure graphicRef100632" href="/z/d/graphic/100632.html" rel="external">
          figure 1
         </a>
         ). In light of the high rate of urinary tract anomalies in both nonsyndromic (20 percent) and syndromic (40 percent) HD, some experts recommend ultrasonographic screening for urinary system malformations in all patients with HD [
         <a href="#rid22">
          22
         </a>
         ], but practice varies. All HD patients should undergo routine screening for hearing impairment, using protocols for infants at increased risk. (See
         <a class="local">
          'Associated congenital anomalies'
         </a>
         above.)
        </p>
        <p>
         Assessment by a clinical geneticist is valuable for all patients with syndromic features or anomalies and also for those with no apparent associated anomalies. Genetic screening for multiple endocrine neoplasia type 2A (MEN2A) may be offered to the families of infants with HD and particularly for those with a family history of MEN2 or related neoplasms in first-degree relatives. (See
         <a class="local">
          'Associated syndromes'
         </a>
         above and
         <a class="local">
          'Associated congenital anomalies'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/7870.html" rel="external">
          "Clinical manifestations and diagnosis of multiple endocrine neoplasia type 2", section on 'Genetic screening'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H609909266">
         <span class="h1">
          ULTRASHORT-SEGMENT HIRSCHSPRUNG DISEASE
         </span>
         <span class="headingEndMark">
          —
         </span>
         The term "ultrashort-segment HD" (USSHD) is sometimes used to describe a form characterized by a very short segment of aganglionosis extending 2 to 4 cm proximal to the internal anal sphincter. Most experts agree that this form exists, although there is some controversy on this point.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical presentation
         </strong>
         – The clinical picture is similar to the classical short-segment HD (which involves most or all of the rectum and part of the sigmoid colon), except that the degree of constipation may be less severe and the complications of growth retardation and enterocolitis are less likely to develop. On contrast enema, the dilated rectum may extend to the level of the internal sphincter and there may not be a visible transition zone.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Anorectal manometry is a useful screening test for suspected USSHD. In children with USSHD, the anorectal inhibitory reflex is absent, as it is in the other forms of HD. The lack of anorectal relaxation is the physiologic basis for the clinical features. By contrast, people with other forms of constipation have a normal anorectal inhibitory reflex.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – The diagnosis of USSHD is established by taking two biopsies:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A biopsy taken just proximal to the dentate line that shows aganglionosis – This distinguishes USSHD from internal anal sphincter achalasia (which has similar findings on anorectal manometry, but in achalasia, ganglion cells are present). (See
         <a class="medical medical_review" href="/z/d/html/99538.html" rel="external">
          "Functional constipation in infants, children, and adolescents: Clinical features and diagnosis", section on 'Internal anal sphincter achalasia'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A biopsy taken approximately 4 cm above the internal sphincter that shows normal ganglion cells – This biopsy distinguishes USSHD from classical HD, in which ganglion cells would be absent.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Management
         </strong>
         – It is important to distinguish patients with USSHD from those with typical HD because patients with USSHD may not require a pull-through operation. Some patients with USSHD respond to bowel management with diet, stool softeners, and laxatives. Others respond to botulinum toxin injections. If these measures fail, a myomectomy should be considered, removing a 0.5 to 1.0 cm-wide strip of inner circular muscle in the posterior midline, from the level of the internal anal sphincter to the level of the normal ganglionated bowel.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h1">
          POSTOPERATIVE OUTCOMES AND MANAGEMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although many patients achieve normal or near-normal bowel function, abnormalities of bowel function are common after definitive surgery for HD. Overall quality of life (QOL) is generally good, even when bowel function is not normal [
         <a href="#rid83">
          83-90
         </a>
         ]. The most common long-term complications are constipation, fecal incontinence, and enterocolitis. Fecal incontinence has the greatest impact on QOL. Patients with Down syndrome or other syndromes are more likely to have constipation or incontinence [
         <a href="#rid91">
          91
         </a>
         ].
        </p>
        <p>
         Total colonic aganglionosis (TCA) has a much higher rate of complications and mortality before and after definitive treatment compared with the more common forms of HD, in which a smaller portion of the colon is affected [
         <a href="#rid32">
          32,92
         </a>
         ]. TCA also has a much higher risk for enterocolitis and poor functional results, including chronic diarrhea and fecal incontinence after surgery. These symptoms are often associated with severe skin irritation, excoriation, and frank breakdown in the diaper area. Some patients, especially those with residual aganglionosis or stricture formation, may benefit from a redo pull-through procedure [
         <a href="#rid93">
          93
         </a>
         ]. In general, bowel function tends to improve over time [
         <a href="#rid94">
          94
         </a>
         ]. Patients with TCA involving the small bowel also at risk for intestinal failure and related complications [
         <a href="#rid32">
          32
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5886.html" rel="external">
          "Chronic complications of short bowel syndrome in children"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Constipation
         </strong>
         – Constipation or persistent obstructive symptoms, which include vomiting, bloating, borborygmi, abdominal distension, and severe constipation, occur in 10 to 30 percent of patients after operative repair for HD [
         <a href="#rid95">
          95
         </a>
         ]. This can be caused by an anatomic mechanical obstruction (eg, stricture, twist or kink in the pull-through segment, scarring of the muscular cuff following the Soave procedure, or stool collecting in a long "spur" after a Duhamel procedure), persistent or acquired aganglionosis, a colonic motility disorder (eg, intestinal neuronal dysplasia), increased internal anal sphincter tone, or nonspecific colonic dysmotility/stool-withholding behavior [
         <a href="#rid96">
          96,97
         </a>
         ]. The diagnostic evaluation typically includes a radiographic contrast study to evaluate for stricture, a full-thickness rectal biopsy to evaluate for persistent aganglionosis, and an assessment of motility (eg, radiopaque marker study, radionuclide colonic transit study, or colonic manometry).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Guidelines for the management of postoperative obstructive symptoms in children with HD have been published by the American Pediatric Surgical Association [
         <a href="#rid95">
          95
         </a>
         ]. Anatomic or pathologic etiologies identified in the evaluation of persistent obstructive symptoms can be addressed with surgical revision or redo pull-through. If increased internal anal sphincter tone is suspected, a trial of botulinum toxin injection may be helpful diagnostically and therapeutically  (
         <a class="graphic graphic_algorithm graphicRef78219" href="/z/d/graphic/78219.html" rel="external">
          algorithm 2
         </a>
         ) [
         <a href="#rid98">
          98-100
         </a>
         ]. In many cases, obstructive symptoms improve or resolve with time [
         <a href="#rid86">
          86
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Enterocolitis
         </strong>
         – Despite surgical repair, Hirschsprung-associated enterocolitis (HAEC) is a major cause of postoperative morbidity and occasional mortality, with postoperative incidence rates as high as 45 percent [
         <a href="#rid48">
          48,91,101-103
         </a>
         ]. It usually occurs within the first year after surgical repair and rarely occurs more than five years postoperatively [
         <a href="#rid102">
          102,104
         </a>
         ]. HAEC is also more common in long-segment disease, especially TCA. Use of home rectal irrigations may reduce the need for hospitalization for HAEC [
         <a href="#rid105">
          105
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The risk for HAEC appears to be increased in patients with an anastomotic stricture, suggesting that intestinal stasis may have a role in the etiology [
         <a href="#rid102">
          102
         </a>
         ]. HAEC is more likely to develop after the pull-through operation if there is histologic evidence of inflammation in the resected colon [
         <a href="#rid106">
          106
         </a>
         ]. The risk is also increased in patients with long-segment disease, particularly for patients with TCA [
         <a href="#rid101">
          101,107,108
         </a>
         ]; such patients also have increased risks for perianal excoriations, electrolyte imbalance, and anastomotic leak as compared with patients with rectosigmoid disease [
         <a href="#rid109">
          109
         </a>
         ]. The risk for these problems tends to diminish with more time after surgery.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         A few reports have suggested an association between HAEC and subsequent development of inflammatory bowel disease (IBD) [
         <a href="#rid110">
          110-112
         </a>
         ]. In a multicenter retrospective study, TCA, trisomy 21, and HAEC were identified as risk factors for Hirschsprung-associated IBD. The authors recommend that children with unexplained fistulae, HAEC after age five or that is refractory to standard therapy, and symptoms suggestive of IBD should be evaluated for IBD [
         <a href="#rid112">
          112
         </a>
         ]. The risk factors, clinical presentation, and management of HAEC are discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/5891.html" rel="external">
          "Emergency complications of Hirschsprung disease", section on 'Enterocolitis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Incontinence
         </strong>
         – Diarrhea and incontinence are common during the early postoperative period, but they seem to improve with time [
         <a href="#rid113">
          113
         </a>
         ]. Loss of water-absorptive surface area from colonic resection and anal sphincter dysfunction are likely etiologic factors. The latter may be due to damage to the anal canal and internal sphincter during the pull-through operation [
         <a href="#rid82">
          82,114
         </a>
         ]. Improvement of bowel function occurs in the majority of patients with frequency of stools and continence improving with age [
         <a href="#rid78">
          78,83,101,107,113,115,116
         </a>
         ]. In most patients, there is a rapid decrease in stool frequency during the first six months postoperatively, with a slower decline over the next several years [
         <a href="#rid78">
          78
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Long-term follow-up reveals that approximately 75 to 95 percent of patients achieve a stool frequency of five or fewer stools per day [
         <a href="#rid107">
          107,115,116
         </a>
         ]. Some patients may have persistent problems with constipation and fecal incontinence [
         <a href="#rid107">
          107,115-119
         </a>
         ]. In one long-term study, 42 percent of patients had occasional soiling and 12 percent had frequent soiling [
         <a href="#rid91">
          91
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         For patients with fecal incontinence following pull-through surgery, rectal examination under anesthesia, anorectal manometry, and contrast enema can help distinguish the underlying cause and guide management [
         <a href="#rid97">
          97,100,120
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Incontinence – Indicated by poor anorectal sensation or sphincter weakness on anorectal manometry. For these patients, management may include dietary modification and bowel management and/or more invasive options (eg, diverting ostomy).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Pseudoincontinence – Indicated by fecal soiling with normal anorectal sensation and sphincter function on anorectal manometry. The cause can be further categorized based on the results of a contrast enema, with or without colonic motility studies:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Fecal impaction with overflow leakage – Suggested by a dilated neo-rectum; these patients are managed with a conventional constipation regimen
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Hypermotility – Suggested by normal-caliber neo-rectum; these patients are managed with bulking agents and antimotility medications
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Over time, most patients with pseudoincontinence will improve. However, most patients with Down syndrome and HD continue to have disturbed bowel function (soiling, recurrent enterocolitis) over the long term and some resort to a permanent colostomy [
         <a href="#rid91">
          91,121
         </a>
         ]. For most patients with HD, the disease-specific QOL tends to improve as time passes; those with total colonic HD are more likely to report problems with psychosocial adjustment [
         <a href="#rid85">
          85,122
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Urologic and sexual outcomes
         </strong>
         – Urologic and sexual complications, specifically urinary incontinence and erectile dysfunction, have been reported after surgery for HD [
         <a href="#rid119">
          119,123-125
         </a>
         ]. Several studies suggest that these problems are no more common than in matched controls [
         <a href="#rid123">
          123,126
         </a>
         ]. However, caution is appropriate since urinary and sexual dysfunction are known to occur after other types of pelvic surgery and because these problems may not be recognized until years later. One long-term follow-up study found a difference in fertility and sexual QOL between adult men and women [
         <a href="#rid127">
          127
         </a>
         ]. Most men had normal fertility and sexual QOL after surgery for HD, whereas fertility and sexual QOL were often reduced in women. Dyspareunia was one of the outcomes that accounted for the reduced sexual QOL. As is true for overall QOL, poor bowel function was also associated with these problems. Prospective documentation of urologic and sexual outcomes in all Hirschsprung cases has been suggested [
         <a href="#rid124">
          124
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H286057501">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topic (see
         <a class="medical medical_basics" href="/z/d/html/82944.html" rel="external">
          "Patient education: Hirschsprung disease (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Disease spectrum
         </strong>
         – Hirschsprung disease (HD) is caused by congenital absence of ganglion cells in the distal rectum and extends proximally into the colon for a variable distance. It affects the rectum and part of the sigmoid colon in approximately 80 percent of patients, but it also can involve more proximal segments, the entire colon, or (in rare cases) most of the small bowel. (See
         <a class="local">
          'Types of aganglionosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Associated syndromes and anomalies
         </strong>
         – There is an increased risk for HD among patients with trisomy 21 and several other genetic syndromes  (
         <a class="graphic graphic_table graphicRef73215" href="/z/d/graphic/73215.html" rel="external">
          table 2
         </a>
         ). Assessment by a clinical geneticist is valuable for all patients with syndromic features or anomalies, as well as for those with no apparent associated anomalies. (See
         <a class="local">
          'Associated syndromes'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         For all patients with HD, and particularly those with syndromic HD, genitourinary anomalies, hearing impairment, and visual impairment are common  (
         <a class="graphic graphic_figure graphicRef100632" href="/z/d/graphic/100632.html" rel="external">
          figure 1
         </a>
         ). Congenital heart disease is common among those with syndromic HD. The clinician should be alert for signs or symptoms of congenital anomalies in patients with suspected HD. (See
         <a class="local">
          'Associated congenital anomalies'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical presentation
         </strong>
         – (See
         <a class="local">
          'Clinical presentation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The majority of patients with HD are diagnosed in the neonatal period when they present with symptoms of distal intestinal obstruction, including bilious emesis, abdominal distension, and failure to pass stool. A high index of suspicion is appropriate for infants with a predisposing condition such as Down syndrome or for those with a family history of HD.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Occasionally, affected infants may present with Hirschsprung-associated enterocolitis (HAEC), a potentially life-threatening illness in which patients have a sepsis-like picture with fever, vomiting, diarrhea, and abdominal distension, which can progress to toxic megacolon. (See
         <a class="medical medical_review" href="/z/d/html/5891.html" rel="external">
          "Emergency complications of Hirschsprung disease", section on 'Enterocolitis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Patients with less severe (short-segment or ultrashort-segment) HD may not be diagnosed until later in infancy or childhood. Such patients typically have a history of chronic constipation and failure to thrive. Patients with ultrashort-segment HD may not require a pull-through operation. (See
         <a class="local">
          'Ultrashort-segment Hirschsprung disease'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Indications for evaluation in a neonate
         </strong>
         – An urgent full evaluation for HD is appropriate for newborns or young infants (&lt;6 months old) with the following features (see
         <a class="local">
          'Suspected Hirschsprung disease in neonates'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Symptoms of obstruction (bilious emesis, abdominal distension, and failure to pass stool)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Failure to pass meconium within 48 hours of birth
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Constipation and trisomy 21 or other condition known to be associated with HD, or a family history of HD
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Constipation and physical examination suggestive of HD (tight anal sphincter; narrowed, empty rectum; or squirt sign on digital examination)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Evaluation and diagnosis
         </strong>
         – Definitive diagnosis of HD is made by rectal biopsy, which may be supported by findings on abdominal radiographs, contrast enema, or anorectal manometry. The diagnostic steps depend on the level of suspicion for HD, whether there is concern about enterocolitis (HAEC, which requires emergency management), age of the child, and on the available resources and institutional/clinician preference  (
         <a class="graphic graphic_algorithm graphicRef51156" href="/z/d/graphic/51156.html" rel="external">
          algorithm 1
         </a>
         ). (See
         <a class="local">
          'Evaluation'
         </a>
         above and
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Initial management
         </strong>
         – The treatment for HD is surgical resection of the aganglionic segment of bowel. The normal ganglionic bowel is brought down and anastomosed just proximal to the anus with care to avoid damage to the internal anal sphincter. (See
         <a class="local">
          'Management'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Outcomes
         </strong>
         – Abnormalities of bowel function are common after definitive surgery for HD, although overall quality of life (QOL) is generally good. The most common long-term complications are constipation  (
         <a class="graphic graphic_algorithm graphicRef78219" href="/z/d/graphic/78219.html" rel="external">
          algorithm 2
         </a>
         ) and fecal incontinence. Postoperative enterocolitis may also occur and is a medical emergency. (See
         <a class="local">
          'Postoperative outcomes and management'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/5891.html" rel="external">
          "Emergency complications of Hirschsprung disease"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2348441871">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges David E Wesson, MD, who contributed to earlier versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Suita S, Taguchi T, Ieiri S, Nakatsuji T. Hirschsprung's disease in Japan: analysis of 3852 patients based on a nationwide survey in 30 years. J Pediatr Surg 2005; 40:197.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Best KE, Addor MC, Arriola L, et al. Hirschsprung's disease prevalence in Europe: a register based study. Birth Defects Res A Clin Mol Teratol 2014; 100:695.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ieiri S, Suita S, Nakatsuji T, et al. Total colonic aganglionosis with or without small bowel involvement: a 30-year retrospective nationwide survey in Japan. J Pediatr Surg 2008; 43:2226.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Badner JA, Sieber WK, Garver KL, Chakravarti A. A genetic study of Hirschsprung disease. Am J Hum Genet 1990; 46:568.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fu M, Tam PK, Sham MH, Lui VC. Embryonic development of the ganglion plexuses and the concentric layer structure of human gut: a topographical study. Anat Embryol (Berl) 2004; 208:33.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McKeown SJ, Stamp L, Hao MM, Young HM. Hirschsprung disease: a developmental disorder of the enteric nervous system. Wiley Interdiscip Rev Dev Biol 2013; 2:113.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goldstein AM, Hofstra RM, Burns AJ. Building a brain in the gut: development of the enteric nervous system. Clin Genet 2013; 83:307.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Amiel J, Sproat-Emison E, Garcia-Barcelo M, et al. Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet 2008; 45:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tilghman JM, Ling AY, Turner TN, et al. Molecular Genetic Anatomy and Risk Profile of Hirschsprung's Disease. N Engl J Med 2019; 380:1421.
          </a>
         </li>
         <li class="breakAll">
          Parisi MA. GeneReviews: Hirschsprung Disease Overview. 2015. Available at: http://www.ncbi.nlm.nih.gov/books/NBK1439/ (Accessed on May 01, 2019).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fitze G, Cramer J, Ziegler A, et al. Association between c135G/A genotype and RET proto-oncogene germline mutations and phenotype of Hirschsprung's disease. Lancet 2002; 359:1200.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim JH, Yoon KO, Kim JK, et al. Novel mutations of RET gene in Korean patients with sporadic Hirschsprung's disease. J Pediatr Surg 2006; 41:1250.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moore SW, Zaahl M. Clinical and genetic differences in total colonic aganglionosis in Hirschsprung's disease. J Pediatr Surg 2009; 44:1899.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Uesaka T, Nagashimada M, Yonemura S, Enomoto H. Diminished Ret expression compromises neuronal survival in the colon and causes intestinal aganglionosis in mice. J Clin Invest 2008; 118:1890.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Uesaka T, Jain S, Yonemura S, et al. Conditional ablation of GFRalpha1 in postmigratory enteric neurons triggers unconventional neuronal death in the colon and causes a Hirschsprung's disease phenotype. Development 2007; 134:2171.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sánchez-Mejías A, Fernández RM, López-Alonso M, et al. New roles of EDNRB and EDN3 in the pathogenesis of Hirschsprung disease. Genet Med 2010; 12:39.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jannot AS, Pelet A, Henrion-Caude A, et al. Chromosome 21 scan in Down syndrome reveals DSCAM as a predisposing locus in Hirschsprung disease. PLoS One 2013; 8:e62519.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moore SW. Advances in understanding the association between Down syndrome and Hirschsprung disease (DS-HSCR). Pediatr Surg Int 2018; 34:1127.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martucciello G, Ceccherini I, Lerone M, Jasonni V. Pathogenesis of Hirschsprung's disease. J Pediatr Surg 2000; 35:1017.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bajaj R, Smith J, Trochet D, et al. Congenital central hypoventilation syndrome and Hirschsprung's disease in an extremely preterm infant. Pediatrics 2005; 115:e737.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garcia-Barcelo MM, Tang CS, Ngan ES, et al. Genome-wide association study identifies NRG1 as a susceptibility locus for Hirschsprung's disease. Proc Natl Acad Sci U S A 2009; 106:2694.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pini Prato A, Rossi V, Mosconi M, et al. A prospective observational study of associated anomalies in Hirschsprung's disease. Orphanet J Rare Dis 2013; 8:184.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Menezes M, Puri P. Long-term clinical outcome in patients with Hirschsprung's disease and associated Down's syndrome. J Pediatr Surg 2005; 40:810.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bull MJ, Committee on Genetics. Health supervision for children with Down syndrome. Pediatrics 2011; 128:393.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bonnard A, Zeidan S, Degas V, et al. Outcomes of Hirschsprung's disease associated with Mowat-Wilson syndrome. J Pediatr Surg 2009; 44:587.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saunders CJ, Zhao W, Ardinger HH. Comprehensive ZEB2 gene analysis for Mowat-Wilson syndrome in a North American cohort: a suggested approach to molecular diagnostics. Am J Med Genet A 2009; 149A:2527.
          </a>
         </li>
         <li class="breakAll">
          Adam MP, Bean LJH, Miller VR. Mowat-Wilson Syndrome (Hirschprung disease-mental retardation syndrome). Gene Reviews 2008. Available at: http://www.ncbi.nlm.nih.gov/books/NBK1412/.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parisi MA, Kapur RP. Genetics of Hirschsprung disease. Curr Opin Pediatr 2000; 12:610.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Flori E, Girodon E, Samama B, et al. Trisomy 7 mosaicism, maternal uniparental heterodisomy 7 and Hirschsprung's disease in a child with Silver-Russell syndrome. Eur J Hum Genet 2005; 13:1013.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mueller C, Patel S, Irons M, et al. Normal cognition and behavior in a Smith-Lemli-Opitz syndrome patient who presented with Hirschsprung disease. Am J Med Genet A 2003; 123A:100.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Pontual L, Pelet A, Clement-Ziza M, et al. Epistatic interactions with a common hypomorphic RET allele in syndromic Hirschsprung disease. Hum Mutat 2007; 28:790.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Payen E, Talbotec C, Chardot C, et al. Outcome of Total Colonic Aganglionosis Involving the Small Bowel Depends on Bowel Length, Liver Disease, and Enterocolitis. J Pediatr Gastroenterol Nutr 2022; 74:582.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khan AR, Vujanic GM, Huddart S. The constipated child: how likely is Hirschsprung's disease? Pediatr Surg Int 2003; 19:439.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clark DA. Times of first void and first stool in 500 newborns. Pediatrics 1977; 60:457.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Klein MD, Coran AG, Wesley JR, Drongowski RA. Hirschsprung's disease in the newborn. J Pediatr Surg 1984; 19:370.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Singh SJ, Croaker GD, Manglick P, et al. Hirschsprung's disease: the Australian Paediatric Surveillance Unit's experience. Pediatr Surg Int 2003; 19:247.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bradnock TJ, Knight M, Kenny S, et al. Hirschsprung's disease in the UK and Ireland: incidence and anomalies. Arch Dis Child 2017; 102:722.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lall A, Gupta DK, Bajpai M. Neonatal Hirschsprung's disease. Indian J Pediatr 2000; 67:583.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sarioğlu A, Tanyel FC, Büyükpamukçu N, Hiçsönmez A. Appendiceal perforation: a potentially lethal initial mode of presentation of Hirschsprung's disease. J Pediatr Surg 1997; 32:123.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Constipation Guideline Committee of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Evaluation and treatment of constipation in infants and children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2006; 43:e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arshad A, Powell C, Tighe MP. Hirschsprung's disease. BMJ 2012; 345:e5521.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wheatley MJ, Wesley JR, Coran AG, Polley TZ Jr. Hirschsprung's disease in adolescents and adults. Dis Colon Rectum 1990; 33:622.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Crocker NL, Messmer JM. Adult Hirschsprung's disease. Clin Radiol 1991; 44:257.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sarioglu A, Tanyel FC, Büyükpamukçu N, Hiçsönmez A. Hirschsprung-associated congenital anomalies. Eur J Pediatr Surg 1997; 7:331.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pini Prato A, Musso M, Ceccherini I, et al. Hirschsprung disease and congenital anomalies of the kidney and urinary tract (CAKUT): a novel syndromic association. Medicine (Baltimore) 2009; 88:83.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hofmann AD, Duess JW, Puri P. Congenital anomalies of the kidney and urinary tract (CAKUT) associated with Hirschsprung's disease: a systematic review. Pediatr Surg Int 2014; 30:757.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hofmann AD, Puri P. Association of Hirschsprung's disease and anorectal malformation: a systematic review. Pediatr Surg Int 2013; 29:913.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gosain A, Frykman PK, Cowles RA, et al. Guidelines for the diagnosis and management of Hirschsprung-associated enterocolitis. Pediatr Surg Int 2017; 33:517.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nofech-Mozes Y, Rachmel A, Schonfeld T, et al. Difficulties in making the diagnosis of Hirschsprung disease in early infancy. J Paediatr Child Health 2004; 40:716.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           De Lorijn F, Reitsma JB, Voskuijl WP, et al. Diagnosis of Hirschsprung's disease: a prospective, comparative accuracy study of common tests. J Pediatr 2005; 146:787.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Putnam LR, John SD, Greenfield SA, et al. The utility of the contrast enema in neonates with suspected Hirschsprung disease. J Pediatr Surg 2015; 50:963.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carroll AG, Kavanagh RG, Ni Leidhin C, et al. Comparative Effectiveness of Imaging Modalities for the Diagnosis of Intestinal Obstruction in Neonates and Infants:: A Critically Appraised Topic. Acad Radiol 2016; 23:559.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Proctor ML, Traubici J, Langer JC, et al. Correlation between radiographic transition zone and level of aganglionosis in Hirschsprung's disease: Implications for surgical approach. J Pediatr Surg 2003; 38:775.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stranzinger E, DiPietro MA, Teitelbaum DH, Strouse PJ. Imaging of total colonic Hirschsprung disease. Pediatr Radiol 2008; 38:1162.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Doig CM. Hirschsprung's disease and mimicking conditions. Dig Dis 1994; 12:106.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garcia R, Arcement C, Hormaza L, et al. Use of the recto-sigmoid index to diagnose Hirschsprung's disease. Clin Pediatr (Phila) 2007; 46:59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lourenção PLTA, Valerini FG, Cataneo AJM, et al. Barium Enema Revisited in the Workup for the Diagnosis of Hirschsprung's Disease. J Pediatr Gastroenterol Nutr 2019; 68:e62.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Lorijn F, Kremer LC, Reitsma JB, Benninga MA. Diagnostic tests in Hirschsprung disease: a systematic review. J Pediatr Gastroenterol Nutr 2006; 42:496.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Downey EC, Hughes E, Putnam AR, et al. Hirschsprung disease in the premature newborn: a population based study and 40-year single center experience. J Pediatr Surg 2015; 50:123.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lewis NA, Levitt MA, Zallen GS, et al. Diagnosing Hirschsprung's disease: increasing the odds of a positive rectal biopsy result. J Pediatr Surg 2003; 38:412.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tang YF, Chen JG, An HJ, et al. High-resolution anorectal manometry in newborns: normative values and diagnostic utility in Hirschsprung disease. Neurogastroenterol Motil 2014; 26:1565.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meinds RJ, Trzpis M, Broens PMA. Anorectal Manometry May Reduce the Number of Rectal Suction Biopsy Procedures Needed to Diagnose Hirschsprung Disease. J Pediatr Gastroenterol Nutr 2018; 67:322.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alizai NK, Batcup G, Dixon MF, Stringer MD. Rectal biopsy for Hirschsprung's disease: what is the optimum method? Pediatr Surg Int 1998; 13:121.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kapur RP. Practical pathology and genetics of Hirschsprung's disease. Semin Pediatr Surg 2009; 18:212.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Croffie JM, Davis MM, Faught PR, et al. At what age is a suction rectal biopsy less likely to provide adequate tissue for identification of ganglion cells? J Pediatr Gastroenterol Nutr 2007; 44:198.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schofield DE, Devine W, Yunis EJ. Acetylcholinesterase-stained suction rectal biopsies in the diagnosis of Hirschsprung's disease. J Pediatr Gastroenterol Nutr 1990; 11:221.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lake BD, Puri P, Nixon HH, Claireaux AE. Hirschsprung's disease: an appraisal of histochemically demonstrated acetylcholinesterase activity in suction rectal biopsy specimens as an aid to diagnosis. Arch Pathol Lab Med 1978; 102:244.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barshack I, Fridman E, Goldberg I, et al. The loss of calretinin expression indicates aganglionosis in Hirschsprung's disease. J Clin Pathol 2004; 57:712.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Arruda Lourenção PL, Takegawa BK, Ortolan EV, et al. Does calretinin immunohistochemistry reduce inconclusive diagnosis in rectal biopsies for Hirschsprung disease? J Pediatr Gastroenterol Nutr 2014; 58:603.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Janssen Lok M, Rassouli-Kirchmeier R, Köster N, et al. Development of Nerve Fibre Diameter in Young Infants With Hirschsprung Disease. J Pediatr Gastroenterol Nutr 2018; 66:253.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pratap A, Gupta DK, Tiwari A, et al. Application of a plain abdominal radiograph transition zone (PARTZ) in Hirschsprung's disease. BMC Pediatr 2007; 7:5.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buonpane C, Lautz TB, Hu YY. Should we look for Hirschsprung disease in all children with meconium plug syndrome? J Pediatr Surg 2019; 54:1164.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mao YZ, Tang ST, Li S. Duhamel operation vs. transanal endorectal pull-through procedure for Hirschsprung disease: A systematic review and meta-analysis. J Pediatr Surg 2018; 53:1710.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Teitelbaum DH, Cilley RE, Sherman NJ, et al. A decade of experience with the primary pull-through for hirschsprung disease in the newborn period: a multicenter analysis of outcomes. Ann Surg 2000; 232:372.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sulkowski JP, Cooper JN, Congeni A, et al. Single-stage versus multi-stage pull-through for Hirschsprung's disease: practice trends and outcomes in infants. J Pediatr Surg 2014; 49:1619.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huerta CT, Ramsey WA, Davis JK, et al. Nationwide Outcomes of Immediate Versus Staged Surgery for Newborns with Rectosigmoid Hirschsprung Disease. J Pediatr Surg 2023; 58:1101.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bonnard A, de Lagausie P, Leclair MD, et al. Definitive treatment of extended Hirschsprung's disease or total colonic form. Surg Endosc 2001; 15:1301.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coran AG, Teitelbaum DH. Recent advances in the management of Hirschsprung's disease. Am J Surg 2000; 180:382.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Langer JC, Durrant AC, de la Torre L, et al. One-stage transanal Soave pullthrough for Hirschsprung disease: a multicenter experience with 141 children. Ann Surg 2003; 238:569.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Travassos DV, Bax NM, Van der Zee DC. Duhamel procedure: a comparative retrospective study between an open and a laparoscopic technique. Surg Endosc 2007; 21:2163.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thomson D, Allin B, Long AM, et al. Laparoscopic assistance for primary transanal pull-through in Hirschsprung's disease: a systematic review and meta-analysis. BMJ Open 2015; 5:e006063.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stensrud KJ, Emblem R, Bjørnland K. Anal endosonography and bowel function in patients undergoing different types of endorectal pull-through procedures for Hirschsprung disease. J Pediatr Surg 2015; 50:1341.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yanchar NL, Soucy P. Long-term outcome after Hirschsprung's disease: patients' perspectives. J Pediatr Surg 1999; 34:1152.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bai Y, Chen H, Hao J, et al. Long-term outcome and quality of life after the Swenson procedure for Hirschsprung's disease. J Pediatr Surg 2002; 37:639.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ludman L, Spitz L, Tsuji H, Pierro A. Hirschsprung's disease: functional and psychological follow up comparing total colonic and rectosigmoid aganglionosis. Arch Dis Child 2002; 86:348.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dasgupta R, Langer JC. Evaluation and management of persistent problems after surgery for Hirschsprung disease in a child. J Pediatr Gastroenterol Nutr 2008; 46:13.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chumpitazi BP, Nurko S. Defecation disorders in children after surgery for Hirschsprung disease. J Pediatr Gastroenterol Nutr 2011; 53:75.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bjørnland K, Pakarinen MP, Stenstrøm P, et al. A Nordic multicenter survey of long-term bowel function after transanal endorectal pull-through in 200 patients with rectosigmoid Hirschsprung disease. J Pediatr Surg 2017; 52:1458.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thakkar HS, Bassett C, Hsu A, et al. Functional outcomes in Hirschsprung disease: A single institution's 12-year experience. J Pediatr Surg 2017; 52:277.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Neuvonen MI, Kyrklund K, Rintala RJ, Pakarinen MP. Bowel Function and Quality of Life After Transanal Endorectal Pull-through for Hirschsprung Disease: Controlled Outcomes up to Adulthood. Ann Surg 2017; 265:622.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Neuvonen MI, Kyrklund K, Lindahl HG, et al. A population-based, complete follow-up of 146 consecutive patients after transanal mucosectomy for Hirschsprung disease. J Pediatr Surg 2015.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Laughlin DM, Friedmacher F, Puri P. Total colonic aganglionosis: a systematic review and meta-analysis of long-term clinical outcome. Pediatr Surg Int 2012; 28:773.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ralls MW, Coran AG, Teitelbaum DH. Redo pullthrough for Hirschsprung disease. Pediatr Surg Int 2017; 33:455.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Davidson JR, Kyrklund K, Eaton S, et al. Sexual function, quality of life, and fertility in women who had surgery for neonatal Hirschsprung's disease. Br J Surg 2021; 108:e79.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Langer JC, Rollins MD, Levitt M, et al. Guidelines for the management of postoperative obstructive symptoms in children with Hirschsprung disease. Pediatr Surg Int 2017; 33:523.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Langer JC. Persistent obstructive symptoms after surgery for Hirschsprung's disease: development of a diagnostic and therapeutic algorithm. J Pediatr Surg 2004; 39:1458.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ambartsumyan L, Patel D, Kapavarapu P, et al. Evaluation and Management of Postsurgical Patient With Hirschsprung Disease Neurogastroenterology &amp; Motility Committee: Position Paper of North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr 2023; 76:533.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Han-Geurts IJ, Hendrix VC, de Blaauw I, et al. Outcome after anal intrasphincteric Botox injection in children with surgically treated Hirschsprung disease. J Pediatr Gastroenterol Nutr 2014; 59:604.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roorda D, Oosterlaan J, van Heurn E, Derikx J. Intrasphincteric botulinum toxin injections for post-operative obstructive defecation problems in Hirschsprung disease: A retrospective observational study. J Pediatr Surg 2021; 56:1342.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ahmad H, Yacob D, Halleran DR, et al. Evaluation and treatment of the post pull-through Hirschsprung patient who is not doing well; Update for 2022. Semin Pediatr Surg 2022; 31:151164.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reding R, de Ville de Goyet J, Gosseye S, et al. Hirschsprung's disease: a 20-year experience. J Pediatr Surg 1997; 32:1221.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hackam DJ, Filler RM, Pearl RH. Enterocolitis after the surgical treatment of Hirschsprung's disease: risk factors and financial impact. J Pediatr Surg 1998; 33:830.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           El-Sawaf M, Siddiqui S, Mahmoud M, et al. Probiotic prophylaxis after pullthrough for Hirschsprung disease to reduce incidence of enterocolitis: a prospective, randomized, double-blind, placebo-controlled, multicenter trial. J Pediatr Surg 2013; 48:111.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roorda D, Oosterlaan J, van Heurn E, Derikx JPM. Risk factors for enterocolitis in patients with Hirschsprung disease: A retrospective observational study. J Pediatr Surg 2021; 56:1791.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wall N, Kastenberg Z, Zobell S, et al. Use of an enterocolitis triage and treatment protocol in children with Hirschsprung disease reduces hospital admissions. J Pediatr Surg 2020; 55:2371.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cheng S, Wang J, Pan W, et al. Pathologically assessed grade of Hirschsprung-associated enterocolitis in resected colon in children with Hirschsprung's disease predicts postoperative bowel function. J Pediatr Surg 2017; 52:1776.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marty TL, Seo T, Matlak ME, et al. Gastrointestinal function after surgical correction of Hirschsprung's disease: long-term follow-up in 135 patients. J Pediatr Surg 1995; 30:655.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pini Prato A, Gentilino V, Giunta C, et al. Hirschsprung disease: do risk factors of poor surgical outcome exist? J Pediatr Surg 2008; 43:612.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Anupama B, Zheng S, Xiao X. Ten-year experience in the management of total colonic aganglionosis. J Pediatr Surg 2007; 42:1671.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pontarelli EM, Ford HR, Gayer CP. Recent developments in Hirschsprung's-associated enterocolitis. Curr Gastroenterol Rep 2013; 15:340.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Granström AL, Ludvigsson JF, Wester T. Clinical characteristics and validation of diagnosis in individuals with Hirschsprung disease and inflammatory bowel disease. J Pediatr Surg 2021; 56:1799.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sutthatarn P, Lapidus-Krol E, Smith C, et al. Hirschsprung-associated inflammatory bowel disease: A multicenter study from the APSA Hirschsprung disease interest group. J Pediatr Surg 2023; 58:856.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aworanti OM, McDowell DT, Martin IM, Quinn F. Does Functional Outcome Improve with Time Postsurgery for Hirschsprung Disease? Eur J Pediatr Surg 2016; 26:192.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bischoff A, Frischer J, Knod JL, et al. Damaged anal canal as a cause of fecal incontinence after surgical repair for Hirschsprung disease - a preventable and under-reported complication. J Pediatr Surg 2017; 52:549.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moore SW, Albertyn R, Cywes S. Clinical outcome and long-term quality of life after surgical correction of Hirschsprung's disease. J Pediatr Surg 1996; 31:1496.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sherman JO, Snyder ME, Weitzman JJ, et al. A 40-year multinational retrospective study of 880 Swenson procedures. J Pediatr Surg 1989; 24:833.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ieiri S, Nakatsuji T, Akiyoshi J, et al. Long-term outcomes and the quality of life of Hirschsprung disease in adolescents who have reached 18 years or older--a 47-year single-institute experience. J Pediatr Surg 2010; 45:2398.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Allin BSR, Opondo C, Bradnock TJ, et al. Outcomes at five to eight years of age for children with Hirschsprung's disease. Arch Dis Child 2020.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Trinidad S, Garrison A, Encisco EM, et al. Long-Term Male Sexual Function and Fecal Incontinence Outcomes for Adult Patients with Hirschsprung Disease or Anorectal Malformation. J Pediatr Surg 2023; 58:1573.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saadai P, Trappey AF, Goldstein AM, et al. Guidelines for the management of postoperative soiling in children with Hirschsprung disease. Pediatr Surg Int 2019; 35:829.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Menezes M, Puri P. Long-term outcome of patients with enterocolitis complicating Hirschsprung's disease. Pediatr Surg Int 2006; 22:316.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hartman EE, Oort FJ, Aronson DC, et al. Explaining change in quality of life of children and adolescents with anorectal malformations or Hirschsprung disease. Pediatrics 2007; 119:e374.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Neuvonen M, Kyrklund K, Taskinen S, et al. Lower urinary tract symptoms and sexual functions after endorectal pull-through for Hirschsprung disease: controlled long-term outcomes. J Pediatr Surg 2017; 52:1296.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Versteegh HP, Johal NS, de Blaauw I, Stanton MP. Urological and sexual outcome in patients with Hirschsprung disease: A systematic review. J Pediatr Urol 2016; 12:352.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Witvliet MJ, van Gasteren S, van den Hondel D, et al. Predicting sexual problems in young adults with an anorectal malformation or Hirschsprung disease. J Pediatr Surg 2018; 53:1555.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hoel AT, Karlsen RA, Fosby MV, Bjørnland K. Sexual function and lower urinary tract symptoms after minimally invasive endorectal pull-through in adolescent males with Hirschsprung disease. J Pediatr Surg 2023; 58:490.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Davidson JR, Kyrklund K, Eaton S, et al. Long-term surgical and patient-reported outcomes of Hirschsprung Disease. J Pediatr Surg 2021; 56:1502.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5903 Version 44.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15868585" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Hirschsprung's disease in Japan: analysis of 3852 patients based on a nationwide survey in 30 years.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25066220" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Hirschsprung's disease prevalence in Europe: a register based study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19040940" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Total colonic aganglionosis with or without small bowel involvement: a 30-year retrospective nationwide survey in Japan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2309705" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : A genetic study of Hirschsprung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14991401" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Embryonic development of the ganglion plexuses and the concentric layer structure of human gut: a topographical study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23799632" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Hirschsprung disease: a developmental disorder of the enteric nervous system.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23167617" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Building a brain in the gut: development of the enteric nervous system.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17965226" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Hirschsprung disease, associated syndromes and genetics: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30970187" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Molecular Genetic Anatomy and Risk Profile of Hirschsprung's Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30970187" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Molecular Genetic Anatomy and Risk Profile of Hirschsprung's Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11955539" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Association between c135G/A genotype and RET proto-oncogene germline mutations and phenotype of Hirschsprung's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16818057" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Novel mutations of RET gene in Korean patients with sporadic Hirschsprung's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19853744" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Clinical and genetic differences in total colonic aganglionosis in Hirschsprung's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18414682" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Diminished Ret expression compromises neuronal survival in the colon and causes intestinal aganglionosis in mice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17507417" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Conditional ablation of GFRalpha1 in postmigratory enteric neurons triggers unconventional neuronal death in the colon and causes a Hirschsprung's disease phenotype.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20009762" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : New roles of EDNRB and EDN3 in the pathogenesis of Hirschsprung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23671607" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Chromosome 21 scan in Down syndrome reveals DSCAM as a predisposing locus in Hirschsprung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30218169" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Advances in understanding the association between Down syndrome and Hirschsprung disease (DS-HSCR).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10917288" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Pathogenesis of Hirschsprung's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15930201" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Congenital central hypoventilation syndrome and Hirschsprung's disease in an extremely preterm infant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19196962" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Genome-wide association study identifies NRG1 as a susceptibility locus for Hirschsprung's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24267509" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : A prospective observational study of associated anomalies in Hirschsprung's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15937820" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Long-term clinical outcome in patients with Hirschsprung's disease and associated Down's syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21788214" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Health supervision for children with Down syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19302864" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Outcomes of Hirschsprung's disease associated with Mowat-Wilson syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19842203" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Comprehensive ZEB2 gene analysis for Mowat-Wilson syndrome in a North American cohort: a suggested approach to molecular diagnostics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19842203" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Comprehensive ZEB2 gene analysis for Mowat-Wilson syndrome in a North American cohort: a suggested approach to molecular diagnostics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11106284" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Genetics of Hirschsprung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15915162" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Trisomy 7 mosaicism, maternal uniparental heterodisomy 7 and Hirschsprung's disease in a child with Silver-Russell syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14556255" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Normal cognition and behavior in a Smith-Lemli-Opitz syndrome patient who presented with Hirschsprung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17397038" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Epistatic interactions with a common hypomorphic RET allele in syndromic Hirschsprung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35175997" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Outcome of Total Colonic Aganglionosis Involving the Small Bowel Depends on Bowel Length, Liver Disease, and Enterocolitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12698267" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : The constipated child: how likely is Hirschsprung's disease?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/905009" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Times of first void and first stool in 500 newborns.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6481580" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Hirschsprung's disease in the newborn.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12682752" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Hirschsprung's disease: the Australian Paediatric Surveillance Unit's experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28280094" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Hirschsprung's disease in the UK and Ireland: incidence and anomalies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10985000" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Neonatal Hirschsprung's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9021591" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Appendiceal perforation: a potentially lethal initial mode of presentation of Hirschsprung's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16954945" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Evaluation and treatment of constipation in infants and children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23028095" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Hirschsprung's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2193786" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Hirschsprung's disease in adolescents and adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1959304" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Adult Hirschsprung's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9493983" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Hirschsprung-associated congenital anomalies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19282698" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Hirschsprung disease and congenital anomalies of the kidney and urinary tract (CAKUT): a novel syndromic association.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24974188" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Congenital anomalies of the kidney and urinary tract (CAKUT) associated with Hirschsprung's disease: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23948812" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Association of Hirschsprung's disease and anorectal malformation: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28154902" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Guidelines for the diagnosis and management of Hirschsprung-associated enterocolitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15569293" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Difficulties in making the diagnosis of Hirschsprung disease in early infancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15973319" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Diagnosis of Hirschsprung's disease: a prospective, comparative accuracy study of common tests.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25888274" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : The utility of the contrast enema in neonates with suspected Hirschsprung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26857524" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Comparative Effectiveness of Imaging Modalities for the Diagnosis of Intestinal Obstruction in Neonates and Infants:: A Critically Appraised Topic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12720192" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Correlation between radiographic transition zone and level of aganglionosis in Hirschsprung's disease: Implications for surgical approach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18679610" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Imaging of total colonic Hirschsprung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8045027" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Hirschsprung's disease and mimicking conditions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17164511" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Use of the recto-sigmoid index to diagnose Hirschsprung's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30628984" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Barium Enema Revisited in the Workup for the Diagnosis of Hirschsprung's Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16707970" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Diagnostic tests in Hirschsprung disease: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25598107" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Hirschsprung disease in the premature newborn: a population based study and 40-year single center experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12632358" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Diagnosing Hirschsprung's disease: increasing the odds of a positive rectal biopsy result.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25263969" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : High-resolution anorectal manometry in newborns: normative values and diagnostic utility in Hirschsprung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29652729" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Anorectal Manometry May Reduce the Number of Rectal Suction Biopsy Procedures Needed to Diagnose Hirschsprung Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9563023" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Rectal biopsy for Hirschsprung's disease: what is the optimum method?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19782303" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Practical pathology and genetics of Hirschsprung's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17255831" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : At what age is a suction rectal biopsy less likely to provide adequate tissue for identification of ganglion cells?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1697618" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Acetylcholinesterase-stained suction rectal biopsies in the diagnosis of Hirschsprung's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/580561" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Hirschsprung's disease: an appraisal of histochemically demonstrated acetylcholinesterase activity in suction rectal biopsy specimens as an aid to diagnosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15220363" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : The loss of calretinin expression indicates aganglionosis in Hirschsprung's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24345837" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Does calretinin immunohistochemistry reduce inconclusive diagnosis in rectal biopsies for Hirschsprung disease?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28582312" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Development of Nerve Fibre Diameter in Young Infants With Hirschsprung Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17257439" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Application of a plain abdominal radiograph transition zone (PARTZ) in Hirschsprung's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30879740" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Should we look for Hirschsprung disease in all children with meconium plug syndrome?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29137805" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Duhamel operation vs. transanal endorectal pull-through procedure for Hirschsprung disease: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10973387" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : A decade of experience with the primary pull-through for hirschsprung disease in the newborn period: a multicenter analysis of outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25475806" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Single-stage versus multi-stage pull-through for Hirschsprung's disease: practice trends and outcomes in infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36959060" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Nationwide Outcomes of Immediate Versus Staged Surgery for Newborns with Rectosigmoid Hirschsprung Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11727138" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Definitive treatment of extended Hirschsprung's disease or total colonic form.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11137692" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Recent advances in the management of Hirschsprung's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14530728" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : One-stage transanal Soave pullthrough for Hirschsprung disease: a multicenter experience with 141 children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17483999" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Duhamel procedure: a comparative retrospective study between an open and a laparoscopic technique.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25805527" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Laparoscopic assistance for primary transanal pull-through in Hirschsprung's disease: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25783406" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Anal endosonography and bowel function in patients undergoing different types of endorectal pull-through procedures for Hirschsprung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10442612" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Long-term outcome after Hirschsprung's disease: patients' perspectives.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11912526" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Long-term outcome and quality of life after the Swenson procedure for Hirschsprung's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11970929" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Hirschsprung's disease: functional and psychological follow up comparing total colonic and rectosigmoid aganglionosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18162828" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Evaluation and management of persistent problems after surgery for Hirschsprung disease in a child.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21694540" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Defecation disorders in children after surgery for Hirschsprung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28094015" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : A Nordic multicenter survey of long-term bowel function after transanal endorectal pull-through in 200 patients with rectosigmoid Hirschsprung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27912977" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Functional outcomes in Hirschsprung disease: A single institution's 12-year experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28169931" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Bowel Function and Quality of Life After Transanal Endorectal Pull-through for Hirschsprung Disease: Controlled Outcomes up to Adulthood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25783387" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : A population-based, complete follow-up of 146 consecutive patients after transanal mucosectomy for Hirschsprung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22842648" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Total colonic aganglionosis: a systematic review and meta-analysis of long-term clinical outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28040830" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Redo pullthrough for Hirschsprung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33711127" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Sexual function, quality of life, and fertility in women who had surgery for neonatal Hirschsprung's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28180937" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Guidelines for the management of postoperative obstructive symptoms in children with Hirschsprung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15486887" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Persistent obstructive symptoms after surgery for Hirschsprung's disease: development of a diagnostic and therapeutic algorithm.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36720091" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Evaluation and Management of Postsurgical Patient With Hirschsprung Disease Neurogastroenterology&amp;Motility Committee: Position Paper of North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25000353" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Outcome after anal intrasphincteric Botox injection in children with surgically treated Hirschsprung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33288128" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Intrasphincteric botulinum toxin injections for post-operative obstructive defecation problems in Hirschsprung disease: A retrospective observational study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35690463" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Evaluation and treatment of the post pull-through Hirschsprung patient who is not doing well; Update for 2022.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9269974" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Hirschsprung's disease: a 20-year experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9660207" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Enterocolitis after the surgical treatment of Hirschsprung's disease: risk factors and financial impact.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23331802" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Probiotic prophylaxis after pullthrough for Hirschsprung disease to reduce incidence of enterocolitis: a prospective, randomized, double-blind, placebo-controlled, multicenter trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34078551" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Risk factors for enterocolitis in patients with Hirschsprung disease: A retrospective observational study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32553451" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Use of an enterocolitis triage and treatment protocol in children with Hirschsprung disease reduces hospital admissions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28385428" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Pathologically assessed grade of Hirschsprung-associated enterocolitis in resected colon in children with Hirschsprung's disease predicts postoperative bowel function.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7623220" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Gastrointestinal function after surgical correction of Hirschsprung's disease: long-term follow-up in 135 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18405705" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Hirschsprung disease: do risk factors of poor surgical outcome exist?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17923194" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Ten-year experience in the management of total colonic aganglionosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23857117" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Recent developments in Hirschsprung's-associated enterocolitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33276971" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Clinical characteristics and validation of diagnosis in individuals with Hirschsprung disease and inflammatory bowel disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36801072" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Hirschsprung-associated inflammatory bowel disease: A multicenter study from the APSA Hirschsprung disease interest group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25643245" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Does Functional Outcome Improve with Time Postsurgery for Hirschsprung Disease?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27624566" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Damaged anal canal as a cause of fecal incontinence after surgical repair for Hirschsprung disease - a preventable and under-reported complication.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8943109" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Clinical outcome and long-term quality of life after surgical correction of Hirschsprung's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2769553" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : A 40-year multinational retrospective study of 880 Swenson procedures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21129554" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Long-term outcomes and the quality of life of Hirschsprung disease in adolescents who have reached 18 years or older--a 47-year single-institute experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33139346" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : Outcomes at five to eight years of age for children with Hirschsprung's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37221125" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : Long-Term Male Sexual Function and Fecal Incontinence Outcomes for Adult Patients with Hirschsprung Disease or Anorectal Malformation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31201486" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : Guidelines for the management of postoperative soiling in children with Hirschsprung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16463033" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : Long-term outcome of patients with enterocolitis complicating Hirschsprung's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17272599" id="rid121" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          122 : Explaining change in quality of life of children and adolescents with anorectal malformations or Hirschsprung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28341232" id="rid122" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          123 : Lower urinary tract symptoms and sexual functions after endorectal pull-through for Hirschsprung disease: controlled long-term outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27733240" id="rid123" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          124 : Urological and sexual outcome in patients with Hirschsprung disease: A systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29454526" id="rid124" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          125 : Predicting sexual problems in young adults with an anorectal malformation or Hirschsprung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36283850" id="rid125" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          126 : Sexual function and lower urinary tract symptoms after minimally invasive endorectal pull-through in adolescent males with Hirschsprung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33706942" id="rid126" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          127 : Long-term surgical and patient-reported outcomes of Hirschsprung Disease.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
